ID: ALA4448716

Max Phase: Preclinical

Molecular Formula: C15H11N3O2S

Molecular Weight: 297.34

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)Oc1csc2nc(C)n3c4ccccc4nc3c12

Standard InChI:  InChI=1S/C15H11N3O2S/c1-8-16-15-13(12(7-21-15)20-9(2)19)14-17-10-5-3-4-6-11(10)18(8)14/h3-7H,1-2H3

Standard InChI Key:  XOVQRZQBSYRTTA-UHFFFAOYSA-N

Associated Targets(Human)

Adenosine kinase 1481 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 297.34Molecular Weight (Monoisotopic): 297.0572AlogP: 3.33#Rotatable Bonds: 1
Polar Surface Area: 56.49Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.82CX LogP: 1.94CX LogD: 1.94
Aromatic Rings: 4Heavy Atoms: 21QED Weighted: 0.51Np Likeness Score: -1.29

References

1. Köse M, Schiedel AC, Bauer AA, Poschenrieder H, Burbiel JC, Akkinepally RR, Stachel HD, Müller CE..  (2016)  Focused screening to identify new adenosine kinase inhibitors.,  24  (21): [PMID:27595538] [10.1016/j.bmc.2016.08.026]

Source